360 related articles for article (PubMed ID: 33422382)
1. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
Lee JKH; Lam GKL; Shin T; Samson SI; Greenberg DP; Chit A
Vaccine; 2021 Mar; 39 Suppl 1():A24-A35. PubMed ID: 33422382
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis.
Lee JKH; Lam GKL; Shin T; Kim J; Krishnan A; Greenberg DP; Chit A
Expert Rev Vaccines; 2018 May; 17(5):435-443. PubMed ID: 29715054
[TBL] [Abstract][Full Text] [Related]
3. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
Balasubramani GK; Choi WS; Nowalk MP; Zimmerman RK; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Jackson ML; Jackson LA; Chung JR; Spencer S; Fry AM; Patel M; Flannery B;
Vaccine; 2020 Sep; 38(42):6562-6569. PubMed ID: 32800465
[TBL] [Abstract][Full Text] [Related]
4. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
Clin Infect Dis; 2021 Sep; 73(5):816-823. PubMed ID: 33605977
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
van Aalst R; Gravenstein S; Mor V; Mahmud SM; Wilschut J; Postma M; Chit A
Vaccine; 2020 Jan; 38(2):372-379. PubMed ID: 31606249
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season.
Izurieta HS; Lu M; Kelman J; Lu Y; Lindaas A; Loc J; Pratt D; Wei Y; Chillarige Y; Wernecke M; MaCurdy TE; Forshee R
Clin Infect Dis; 2021 Dec; 73(11):e4251-e4259. PubMed ID: 33211809
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
Belongia EA; Levine MZ; Olaiya O; Gross FL; King JP; Flannery B; McLean HQ
Vaccine; 2020 Mar; 38(15):3121-3128. PubMed ID: 32145994
[TBL] [Abstract][Full Text] [Related]
8. Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.
DiazGranados CA; Robertson CA; Talbot HK; Landolfi V; Dunning AJ; Greenberg DP
Vaccine; 2015 Sep; 33(38):4988-93. PubMed ID: 26212007
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis.
Samson SI; Leventhal PS; Salamand C; Meng Y; Seet BT; Landolfi V; Greenberg D; Hollingsworth R
Expert Rev Vaccines; 2019 Mar; 18(3):295-308. PubMed ID: 30689467
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
DiazGranados CA; Dunning AJ; Kimmel M; Kirby D; Treanor J; Collins A; Pollak R; Christoff J; Earl J; Landolfi V; Martin E; Gurunathan S; Nathan R; Greenberg DP; Tornieporth NG; Decker MD; Talbot HK
N Engl J Med; 2014 Aug; 371(7):635-45. PubMed ID: 25119609
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Comber L; O Murchu E; Jordan K; Hawkshaw S; Marshall L; O'Neill M; Teljeur C; Ryan M; Carnahan A; Pérez Martín JJ; Robertson AH; Johansen K; de Jonge J; Krause T; Nicolay N; Nohynek H; Pavlopoulou I; Pebody R; Penttinen P; Soler-Soneira M; Wichmann O; Harrington P
Rev Med Virol; 2023 May; 33(3):e2330. PubMed ID: 35119149
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review.
Colrat F; Thommes E; Largeron N; Alvarez FP
Vaccine; 2021 Mar; 39 Suppl 1():A42-A50. PubMed ID: 33518466
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience.
Nicolay U; Heijnen E; Nacci P; Patriarca PA; Leav B
Int J Infect Dis; 2019 Aug; 85S():S1-S9. PubMed ID: 30926542
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
DiazGranados CA; Saway W; Gouaux J; Baron M; Baker J; Denis M; Jordanov E; Landolfi V; Yau E
Vaccine; 2015 Dec; 33(51):7188-7193. PubMed ID: 26555348
[TBL] [Abstract][Full Text] [Related]
15. High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update.
Lee JKH; Lam GKL; Yin JK; Loiacono MM; Samson SI
Vaccine X; 2023 Aug; 14():100327. PubMed ID: 37333054
[TBL] [Abstract][Full Text] [Related]
16. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
Prasert K; Patumanond J; Praphasiri P; Siriluk S; Ditsungnoen D; Chittaganpich M; Dawood FS; Mott JA; Lindblade KA
Vaccine; 2019 Feb; 37(6):783-791. PubMed ID: 30616956
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
Mcbride WJH; Abhayaratna WP; Barr I; Booy R; Carapetis J; Carson S; De Looze F; Ellis-Pegler R; Heron L; Karrasch J; Marshall H; Mcvernon J; Nolan T; Rawlinson W; Reid J; Richmond P; Shakib S; Basser RL; Hartel GF; Lai MH; Rockman S; Greenberg ME
Vaccine; 2016 Sep; 34(41):4991-4997. PubMed ID: 27595443
[TBL] [Abstract][Full Text] [Related]
20. Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic.
Okoli GN; Racovitan F; Abdulwahid T; Righolt CH; Mahmud SM
Vaccine; 2021 Feb; 39(8):1225-1240. PubMed ID: 33494964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
